Australia’s CSL has opened the first phase of a $170 million plasma products plant that will boost production for the U.S. and Europe as well as Asia-Pacific markets. CSL today said the new facility ...
Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...
CSL says plasma donors can earn up to $100 per donation and as much as $750 per month. Here’s how it works and what to watch ...
Australia's largest pharmaceutical company will cut 3000 jobs globally, with $20bn wiped from the company’s market value. Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results